Docosahexaenoic Acid-Rich Fish Oil Supplementation Improves Body Composition without Influence of the PPAR&#947; Pro12Ala Polymorphism in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial | Zendy

Anahita Mansoori | Zendy; Gity Sotoudeh | Zendy; Mahmoud Djalali | Zendy; Mohammadreza Eshraghian | Zendy; Mohammad Keramatipour | Zendy; Ensieh NasliEsfahani | Zendy; Farzad Shidfar | Zendy; Ehsan Alvandi | Zendy; Omid Toupchian | Zendy; Fariba Koohdani | Zendy

Open Access

Docosahexaenoic Acid-Rich Fish Oil Supplementation Improves Body Composition without Influence of the PPARγ Pro12Ala Polymorphism in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Author(s) -

Anahita Mansoori,

Gity Sotoudeh,

Mahmoud Djalali,

Mohammadreza Eshraghian,

Mohammad Keramatipour,

Ensieh NasliEsfahani,

Farzad Shidfar,

Ehsan Alvandi,

Omid Toupchian,

Fariba Koohdani

Publication year - 2015

Publication title -

lifestyle genomics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.542

H-Index - 30

eISSN - 2504-3188

pISSN - 2504-3161

DOI - 10.1159/000442792

Subject(s) - medicine , adiponectin , endocrinology , fish oil , docosahexaenoic acid , type 2 diabetes , peroxisome proliferator activated receptor , biology , obesity , diabetes mellitus , insulin resistance , polyunsaturated fatty acid , fatty acid , receptor , biochemistry , fishery , fish <actinopterygii>

The aims of this research were to investigate (1) the impact of docosahexaenoic acid (DHA)-rich fish oil supplementation on body composition, plasma adiponectin level, and peroxisome proliferator-activated receptor γ (PPARγ) gene expression, and (2) whether the effect of DHA-rich fish oil supplementation on the aforementioned variables is modulated by PPARγ Pro12Ala polymorphism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research